Prof. Matthis Synofzik, Head of the Section “Translational Genomics of Neurodegenerative Diseases” at the HIH, talks in an interview with the Boston Consulting Group about the role of rare diseases in precision medicine, progress in the development of precision therapies in neurology and how genetic diagnostics has changed the diagnosis of neurodegenerative diseases.